Rexahn recently announced the in-licensing of a delivery platform from the University of Maryland, U.S. This platform, termed Nano-Polymer-Drug Conjugate Systems (NPDCS), involves the use of a targeting agent...
Contact us to learn the benefits of becoming a Lux member.
Or call us now
For North America (Boston Headquarters)
+1 (617) 502-5300
For EMEA (Amsterdam)
+31 20 280 7900
For APAC (Singapore)